| 二甲双胍对前列腺癌合并糖尿病患者疗效影响的Meta分析 |
| |
| 引用本文： | 任凯斌,方欢,裴亮,吕学锋,兰晓煦. 二甲双胍对前列腺癌合并糖尿病患者疗效影响的Meta分析[J]. 现代肿瘤医学, 2021, 0(12): 2099-2103. DOI: 10.3969/j.issn.1672-4992.2021.12.017 |
| |
| 作者姓名： | 任凯斌 方欢 裴亮 吕学锋 兰晓煦 |
| |
| 作者单位： | 山西医科大学第二临床医学院,山西 太原 030001 |
| |
| 摘 要： | 目的:通过Meta分析观察二甲双胍对前列腺癌合并糖尿病患者疗效的影响.方法:检索万方、中国知网、Pubmed、Embase、Cochrane Library等数据库,采用Review Manager 5.3软件进行数据分析.结果:有13篇文献被纳入,共37972名患者.Meta分析结果显示:二甲双胍组可提高患者10年生...
|
| 关 键 词： | 二甲双胍 前列腺癌 糖尿病 Meta分析 |
Meta-analysis of the effect of metformin on prostate cancer patients with diabetes mellitus |
| |
| REN Kaibin,FANG Huan,PEI Liang,LYU Xuefeng,LAN Xiaoxu. Meta-analysis of the effect of metformin on prostate cancer patients with diabetes mellitus[J]. Journal of Modern Oncology, 2021, 0(12): 2099-2103. DOI: 10.3969/j.issn.1672-4992.2021.12.017 |
| |
| Authors: | REN Kaibin FANG Huan PEI Liang LYU Xuefeng LAN Xiaoxu |
| |
| Affiliation: | The Second Clinical Medical College of Shanxi Medical University,Shanxi Taiyuan 030001,China. |
| |
| Abstract: | Objective:To observe the effect of metformin on prostate cancer patients with diabetes mellitus by Meta-analysis.Methods:Wanfang,CNKI,Pubmed,Embase,Cochrane Library and other databases were retrieved,and the data were analyzed by Review Manager 5.3 software.Results:Thirteen literatures were included in the criteria,with a total of 37 972 patients.Meta-analysis showed that metformin group could increase 10-year survival rate (OR=1.95,95%CI:1.13~3.37,P=0.02),5-year non-biochemical recurrence survival rate (OR=1.93,95%CI:1.07~3.47,P=0.03),and reduce 5-year specific death rate of prostate cancer (OR=0.86,95%CI:0.81~0.91,P＜0.000 01).Conclusion:Metformin can improve the prognosis of prostate cancer patients with diabetes mellitus to a certain extent,but the above conclusion still need more and larger sample studies to further prove. |
| |
| Keywords: | metformin prostate cancer diabetes mellitus Meta-analysis |
|
| 点击此处可从《现代肿瘤医学》浏览原始摘要信息 |
|
点击此处可从《现代肿瘤医学》下载免费的PDF全文 |
|
